Fresenius | FRE - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akzo Nobel EUR 68M 26M 2025-06
Alcon AG USD 53M 1000K 2026-06
AstraZeneca USD 340M 144M 2026-06
BASF EUR 236M 15M 2025-12
Bayer EUR 675M 87M 2025-12
Beiersdorf EUR 7.5M 19.5M 2025-06
DaVita Healthcare Partners USD 17.71B 210.12M 2026-06
Demant DKK 424M 26M 2026-06
E.ON EUR 555M 12M 2026-06
Essilor EUR 168M 21M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
Getinge SEK 133M 31M 2026-06
Givaudan CHF 58M 7M 2025-12
GlaxoSmithKline GBP 121M 46M 2026-06
GN Store Nord DKK 286M 10M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Lonza CHF 84M 14M 2025-06
Merck EUR 137M 33M 2026-06
Novartis USD 462M 119M 2026-06
Philips EUR 83M 26M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
RWE EUR 138M 214M 2025-12
Sanofi EUR 287M 109M 2026-06
Smith & Nephew USD 69M 1000K 2025-12